FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

22322511000001102: ThySat 65mg tablets (hameln pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1304551000001117 ThySat 65mg tablets (hameln pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1304561000001119 ThySat 65mg tablets (hameln pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
ThySat 65mg tablets (hameln pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
ThySat 65mg tablets (hameln pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
ThySat 65mg tablets (hameln pharma Ltd) Is a Product containing precisely potassium iodide 65 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
ThySat 65mg tablets (hameln pharma Ltd) Has active ingredient Potassium iodide false Inferred relationship Existential restriction modifier
ThySat 65mg tablets (hameln pharma Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
ThySat 65mg tablets (hameln pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
ThySat 65mg tablets (hameln pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
ThySat 65mg tablets (hameln pharma Ltd) Has specific active ingredient Potassium iodide true Inferred relationship Existential restriction modifier
ThySat 65mg tablets (hameln pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
ThySat 65mg tablets (hameln pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
ThySat 65mg tablets (hameln pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
ThySat 65mg tablets (hameln pharma Ltd) Is a ThySat true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
ThySat 65mg tablets (hameln pharma Ltd) 4 tablet 1 x 4 tablets Has AMP True ThySat 65mg tablets (hameln pharma Ltd) Inferred relationship Existential restriction modifier
ThySat 65mg tablets (hameln pharma Ltd) 10 tablet 1 x 10 tablets Has AMP True ThySat 65mg tablets (hameln pharma Ltd) Inferred relationship Existential restriction modifier
ThySat 65mg tablets (hameln pharma Ltd) 100 tablet 10 x 10 tablets Has AMP True ThySat 65mg tablets (hameln pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start